Canagliflozin reverses doxorubicin-induced cardiotoxicity via restoration of autophagic homeostasis.
Luo J, He M, Liang C, Huang X, Zhu Y, Hu D, Yan J, Li M, Lin H, Liao W, Bin J, Guan Z, Zheng C, Liao Y.
Luo J, et al. Among authors: he m.
Toxicol Appl Pharmacol. 2024 Dec 2;495:117183. doi: 10.1016/j.taap.2024.117183. Online ahead of print.
Toxicol Appl Pharmacol. 2024.
PMID: 39631538
Free article.